Aberrant Complement System Activation in Neurological Disorders

Karolina Ziąbska(Mossakowski Medical Research Institute, Polish Academy of Sciences), Teresa Zalewska(Mossakowski Medical Research Institute, Polish Academy of Sciences), Joanna Sypecka(Mossakowski Medical Research Institute, Polish Academy of Sciences), Paulina Pawelec(Mossakowski Medical Research Institute, Polish Academy of Sciences), Małgorzata Ziemka‐Nałęcz(Mossakowski Medical Research Institute, Polish Academy of Sciences)
International Journal of Molecular Sciences
April 28, 2021
10.3390/ijms22094675
Cited by 56

Related Papers

The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
|Cells|2020|273
The potential neuroprotective role of a histone deacetylase inhibitor, sodium butyrate, after neonatal hypoxia-ischemia
|Journal of Neuroinflammation|2017|107
Insights Into the Neuroinflammatory Responses After Neonatal Hypoxia-Ischemia
|Journal of Neuropathology & Experimental Neurology|2017|104
Effect of the HDAC Inhibitor, Sodium Butyrate, on Neurogenesis in a Rat Model of Neonatal Hypoxia–Ischemia: Potential Mechanism of Action
|Molecular Neurobiology|2019|94
Sodium Butyrate, a Histone Deacetylase Inhibitor, Exhibits Neuroprotective/Neurogenic Effects in a Rat Model of Neonatal Hypoxia-Ischemia
|Molecular Neurobiology|2016|74